Showing results (1-10 of 186) with videos related to
Sort By:
Pageof 19
Current Opinion in Chemical Biology|July 27, 2001
Human antibodies as next generation therapeuticsM A van Dijk, J G van de WinkelJournal of Immunological Methods|February 28, 2001
Multiplex screening for functionally rearranged immunoglobulin variable regions reveals expression of hybridoma-specific aberrant V-genesG Vidarsson, J G van de Winkel, M A van DijkCurrent Opinion in Infectious Diseases|October 13, 2006
Fc receptor and complement receptor-mediated phagocytosis in host defenceG Vidarsson, J G van de WinkelBlood|July 9, 1999
The FcgammaRIa (CD64) ligand binding chain triggers major histocompatibility complex class II antigen presentation independently of its associated FcR gamma-chainM J van Vugt, M J Kleijmeer, T Keler, et al.International Reviews of Immunology|January 1, 1997
Human IgG Fc receptorsI A Heijnen, J G van de WinkelJournal of Hematotherapy|October 1, 1995
A human Fc gamma RI/CD64 transgenic model for in vivo analysis of (bispecific) antibody therapeuticsI A Heijnen, J G Van de WinkelImmunology Today|May 1, 1993
Human IgG Fc receptor heterogeneity: molecular aspects and clinical implicationsJ G van de Winkel, P J CapelImmunology Today|September 1, 1990
Human Fc gamma receptor II: a standby receptor activated by proteolysis?W J Tax, J G van de WinkelImmunogenetics|July 31, 1998
IgG receptor polymorphisms: risk factors for diseaseW van der Pol, J G van de WinkelJournal of Immunology (Baltimore, Md. : 1950)|September 15, 1990
Effect of protease inhibitors on human monocyte IgG Fc receptor II. Evidence that serine esterase activity is essential for Fc gamma RII-mediated bindingJ G van de Winkel, M Jansze, P J CapelPageof 19